NCT06035900View on ClinicalTrials.gov

Evaluation of Safety, Rate and Extent of Absorption of Psilocin Mucate

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2023

Conditions
Side Effect of Drug
Interventions
DRUG

Psilocin

single 4mg dose of psilocin mucate was administered to healthy 10 volunteers

Trial Locations (1)

11910

Pharmaceutical Research Unit, Amman

Sponsors

Lead Sponsor

Lobe Sciences Ltd.
All Listed Sponsors
collaborator

Pharmaceutical Research Unit, Jordan

OTHER

lead

Lobe Sciences Ltd.

INDUSTRY